Platform Technology

Platform Technology

Innovative “Micro Needle Array “Technology enabled 3D Tissue Fabrication with Cell only.
Our Micro Needle Array technology was developed by focusing on cell’s nature to form aggregate. Conventional bioprinting must use scaffold such as Gel. On the other hand, our process enable tissue fabrication without gel, 100% cell only.
This technology is capable of making 3D Tissue piece for in Vitro research which is mimic in Vivo, and aiming for transplantation into human.

Sphere-like cell aggregates are secured in place by skewers.

The aggregates are allowed to fuse on the skewers for a few days.

The skewers are removed and the tissue is allowed to further mature.

3D Bioprinting process


Spheroid (Cell Aggregate) Preparation

Culture enough cells and form Spheroids by aggregating tens of thousands of cells.



Layer spheroids onto needle as programmed 3D Data.



Spheroids shall fuse together and become one structure in a few days.



Remove Needle Array, and conduct further maturation for cells self-organization and relocation.


3D Tissue Structure

3D tissue structure manufactured with Cell only shows long-term safety and efficiency.